OpenAlex
PricingAboutJobs
Log inGet started
Work

PARP Inhibition in Cancer: An Update on Clinical Development

HTML

Year: 2019
Type: review
Source: Targeted Oncology
DOI: 10.1007/s11523-019-00680-2
Authors: Esha Sachdev, Roya Tabatabai, Varun Roy, B. J. Rimel, Monica M. Mita
Institution: Cedars-Sinai Medical Center
Language: English

Topic: PARP inhibition in cancer therapy
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: PARP inhibitors, synthetic lethality, DNA repair deficiency, BRCA mutations, homologous recombination deficiency, olaparib, niraparib, rucaparib, talazoparib, high-grade serous ovarian cancer, metastatic breast cancer, combination therapy, immunotherapy, drug resistance, clinical trial landscape
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2981233955
FWCI: 3.336
Cites: 141
Cited by: 197
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security